Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findings—from the U.S. Food and Drug Administration's ...
Jun 19, 2020
0
0
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections ...
Apr 30, 2020
0
2
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse ...
Apr 8, 2020
0
112
Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the ...
Mar 25, 2020
0
138
A new paper in Nutrition Reviews finds that intake of the flavonoid quercetin can greatly reduce high blood pressure in patients suffering from cardiovascular disease.
Jan 15, 2020
0
5
(HealthDay)—Recall of a cardiac resynchronization therapy pacemaker, which occurred in November 2015, was delayed unnecessarily, according to a report published online Dec. 20 in JAMA Internal Medicine.
Dec 27, 2019
0
2
After years of generalized theories and hypothesis, research has finally pinpointed certain aspects of childhood experience linked to people living longer.
Sep 18, 2019
0
6
Adverse drug events could be avoided by sharing patients' medication histories and previous harmful medication exposures among various health-care facilities. That's one of the key findings of a study published today in CMAJ ...
Jul 19, 2019
0
1
As advances in the treatment of non-small cell lung cancer (NSCLC) extend patients' lives, more of these patients are facing a different threat: adverse cardiovascular events, such as heart attacks and heart failure. A new ...
Jun 10, 2019
0
3
(HealthDay)—In patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), B-cell depletion using several infusions of rituximab over 12 months is not associated with clinical improvement, according to a ...
Apr 6, 2019
0
0
